Cy­cle makes an­oth­er of­fer for Van­da; Ocean Bio­med­ical, Mol­e­cure ink new deal

Plus, news about Gilead Sci­ences and Yuhan:

Van­da gets sec­ond un­so­licit­ed of­fer: Cy­cle Group Hold­ings again sub­mit­ted a pro­pos­al to buy Van­da for

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.